Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Intangibles (2017 - 2025)

Jaguar Health (JAGX) has disclosed Intangibles for 9 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 34.95% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Dec 2025, down 34.95% year-over-year, with the annual reading at $12.0 million for FY2025, 34.95% down from the prior year.
  • Intangibles for Q4 2025 was $12.0 million at Jaguar Health, down from $17.3 million in the prior quarter.
  • The five-year high for Intangibles was $23.9 million in Q1 2021, with the low at $12.0 million in Q4 2025.
  • Average Intangibles over 5 years is $19.5 million, with a median of $20.5 million recorded in 2023.
  • The sharpest move saw Intangibles dropped 0.94% in 2022, then plummeted 34.95% in 2025.
  • Over 5 years, Intangibles stood at $22.7 million in 2021, then dropped by 0.94% to $22.4 million in 2022, then dropped by 10.35% to $20.1 million in 2023, then decreased by 8.14% to $18.5 million in 2024, then crashed by 34.95% to $12.0 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $12.0 million, $17.3 million, and $12.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.